International journal of pharmaceuticsHumansHeLa CellsChlamydia trachomatisAzithromycinSurface-Active Agents
Surfactant-enriched liposomes to enhance azithromycin efficacy in Chlamydia trachomatis infections.
Sara Lugli, Angela Abruzzo, Carola Parolin, Beatrice Vitali, Antonella Marangoni, Marielle Ezekielle Djusse, Michela Battistelli, Maria Laura Bolognesi, Teresa Cerchiara, Barbara Luppi, Federica Bigucci
Published: 202510.1016/j.ijpharm.2025.126357
Abstract
Chlamydia trachomatis is responsible for the most common bacterial sexually transmitted infection. Oral administration of azithromycin (AZT) represents the first-line treatment. However, AZT shows a low oral bioavailability, due to its poor aqueous s…
Preview only. Read the full abstract at the source